WHY WE’RE TALKING BIOLOGICS
The following information has been compiled to help patients and their allies understand the role biologics can play in healthcare. When we reached out to our community about this topic, we found gaps in knowledge that needed attention.
In an effort to close those gaps, we have curated information from the most reliable sources on the subject. Our hope is that this information will lead you to have more productive conversations with your healthcare team that will open doors to new avenues of treatment.
- What are biologics and biosimilars?
- What makes them different from other drugs?
- What role can they play in your health?
How to Make Informed Decisions about Biologic Drugs in Your Treatment Plan
Biosimilars are biologic medicines that are highly similar to the original biologic medicine,sometimes we refer to this as the “name brand.” For the purposes of this e-book, we will refer to them as originator biologics.
- Surabhi Dangi-Garimella, Ph.D., Principal, SDG AdvoHealth, LLC
- Jim Sliney Jr., Director of Patient Outreach, Patients Rising University
Listen to our Podcast Episode about Biosimilars
Podcast hosts Terry Wilcox and Robert “Dr. Bob” Goldberg review what biosimilars are, explore their relationship to drug prices, and discuss the changing role of biosimilars in healthcare and the marketplace.
Patient Attitudes around Cost, Safety & Efficacy
Patient Survey Report
Patients Rising University conducted a survey to better understand patient experiences and attitudes regarding biologics and biosimilars. This report summarizes what we learned.
Survey Results Infographic
This simple infographic illustrates the five big takeaways from our 2020 survey of 127 patients.
Important Articles & Insights
Videos Addressing Biologics & Biosimilars Concerns
The Patient Perspective: Christina
Crossfit competitor and triathlete Christina Wolffe shares her experience using a biosimliar to manage Type 1 Diabetes.
Webinar & Panel Discussion
Terry Wilcox interviews two patients who have experience using biosimilars to treat their conditions.